![Michael Metzger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Metzger
Directeur Général chez
SYNDAX PHARMACEUTICALS, INC.
Fortune : 9 M $ au 31/05/2026
Profil
Michael A. Metzger is Chief Executive Officer & Director at Syndax Pharmaceuticals, Inc. since 2022.
Mr. Metzger serves as Director at Northern Westchester Hospital Association.
Mr. Metzger is Independent Director at Pyxis Oncology, Inc. starting in 2024.
Former roles include President, Chief Executive Officer & Director at Regado Biosciences, Inc. from 2014 to 2015; Independent Director at CTI BioPharma Corp.
from 2017 to 2023; Independent Director at Response Genetics, Inc. from 2010 to 2013; Managing Director at Mesa Partners, Inc. from 1997 to 2001; Director at Tarveda Therapeutics, Inc.; Head-Mergers & Acquisitions at Forest Laboratories, Inc. in 2011; Vice President-Corporate Development at Traws Pharma, Inc. from 2001 to 2006; Chief Operating Officer & Executive Vice President at Mersana Therapeutics, Inc. from 2011 to 2013; and President, Chief Executive & Operating Officer at Tobira Therapeutics, Inc. Education includes undergraduate studies at George Washington University and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/06/2026 | 484 843 ( 0,55% ) | 9 M $ | 31/05/2026 | |
PYXIS ONCOLOGY, INC. -.--% | 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Michael Metzger
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur Général | 03/02/2022 |
| PYXIS ONCOLOGY, INC. | Directeur/Membre du Conseil | 10/06/2024 |
Northern Westchester Hospital Association
 Northern Westchester Hospital Association Hospital/Nursing ManagementHealth Services Provides healthcare and medical services | Directeur/Membre du Conseil | - |
Anciens postes connus de Michael Metzger
| Sociétés | Poste | Fin |
|---|---|---|
| CTI BIOPHARMA CORP. | Directeur/Membre du Conseil | 23/06/2023 |
| TOBIRA THERAPEUTICS INC | Directeur Général | 04/05/2015 |
Regado Biosciences, Inc.
 Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Directeur Général | 01/05/2015 |
| RESPONSE GENETICS, INC | Directeur/Membre du Conseil | - |
| MERSANA THERAPEUTICS | Directeur des opérations | 01/11/2013 |
Formation de Michael Metzger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
52
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells drug products | Health Technology |
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
Traws Pharma, Inc.
 Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
Regado Biosciences, Inc.
Regado Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antithrombotic drugs | Health Technology |
Mersana Therapeutics, Inc.
 Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Response Genetics, Inc.
 Response Genetics, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical and diagnostic services | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Mesa Partners, Inc.
 Mesa Partners, Inc. Investment ManagersFinance Provides financial advisory, management, marketing and web business development services | Finance |
George Washington University
 George Washington University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Westchester Hospital Association
Northern Westchester Hospital Association Hospital/Nursing ManagementHealth Services Provides healthcare and medical services | Health Services |
Tarveda Therapeutics, Inc.
 Tarveda Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops cancer therapeutics and drugs | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tobira Therapeutics, Inc.
 Tobira Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and commercializes therapeutics to treat liver , inflammation, fibrosis & HIV diseases | Health Technology |
Pyxis Oncology, Inc.
 Pyxis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a preclinical oncology company focused on developing an arsenal of next-generation therapeutics | Health Technology |
